Immunogenicity after heterologous third dose COVID-19 vaccination in a heart transplant recipient.

Mehta, Sapna A; Reyentovich, Alex; Montgomery, Robert A; Segev, Dorry L; Gebel, Howard M; Bray, Robert A; Samanovic, Marie I; Cornelius, Amber R; Mulligan, Mark J; Herati, Ramin S

Mehta, Sapna A; Reyentovich, Alex; Montgomery, Robert A; Segev, Dorry L; Gebel, Howard M; Bray, Robert A; Samanovic, Marie I; Cornelius, Amber R; Mulligan, Mark J; Herati, Ramin S.

Mehta SA; New York University Langone Transplant Institute, New York, New York, USA.
Reyentovich A; New York University Grossman School of Medicine, New York, New York, USA.
Montgomery RA; New York University Langone Transplant Institute, New York, New York, USA.
Segev DL; New York University Grossman School of Medicine, New York, New York, USA.
Gebel HM; New York University Langone Transplant Institute, New York, New York, USA.
Bray RA; New York University Grossman School of Medicine, New York, New York, USA.
Samanovic MI; Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Cornelius AR; Department of Pathology, Emory University Hospital, Atlanta, Georgia, USA.
Mulligan MJ; Department of Pathology, Emory University Hospital, Atlanta, Georgia, USA.
Herati RS; New York University Grossman School of Medicine, New York, New York, USA.

Clin Transplant ; 36(4): e14605, 2022 04.

Article in English | MEDLINE | ID: covidwho-1666296

Subject(s)

COVID-19; Heart Transplantation; Antibodies, Viral; COVID-19/epidemiology; COVID-19/prevention & control; COVID-19 Vaccines; Humans; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Heart Transplantation / COVID-19 Type of study: Observational study Topics: Vaccines Limits: Humans Language: English Journal: Clin Transplant Journal subject: Transplantation Year: 2022 Document Type: Article Affiliation country: Ctr.14605

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google